Anti-Rheumatic Rx
Autoinflammatory/Still's Disease Panel - EULAR2020
Drs. Olga Petryna, Petros Efthimiou, Apostolos Kontzias and Jack Cush discuss autoinflammatory highlights from the Virtual EULAR 2020 meeting June 3-6
Gout Review from EULAR2020
Dr. Olga Petryna reviews highlights from the virtual EULAR 2020 meeting June 3-6, 2020
Updated EULAR Recommendations for RA Management
Dr. Kathryn Dao from EULAR2020 Virtual Conference
Imaging and Remission Axial Spondyloarthritis
Dr. Olga Petryna from EULAR2020 Virtual Conference
OP0079 - what MRI findings are most predictive in AxSpa
OP0314 - Drug free remission in AxSpA
MSK Flares with Vedolizumab
Dr. Rachel Tate from EULAR2020 on Abstract FRI0294
Bimekizumab in Ankylosing Spondylitis
Dr. Rachel Tate from EULAR2020 Virtual Conference
Biosimilars in Spondyloarthritis
Dr. Rachel Tate from EULAR2020 Virtual Conference 0632
- ETN Biosimilar in Reactive Arthritis 0650
- Treasure Study in infliximab biosimilar in SpA
Easier Early Arthritis
Dr. David Liew from EULAR2020 Virtual Conference
Early Patient Referrals
Preclinical RA patients
Enticing New Options in ANCA-Associated Vasculitis
Dr. David Liew from EULAR2020 ANCA-Associated Vasculitis Avacopan vs Prednisone MAINRITSAN 2 study - Calprotectin
Lupus Management at EULAR 2020
Dr. Kathryn Dao highlights SLE presentations from virtual EULAR 2020 meeting June 3-6, 2020
- HCQ levels predicts VTE
- Can you withdraw MMF in stable SLE patients?
-Updated EULAR Lupus Treatment guidelines
Poster Hall